Have a personal or library account? Click to login
Antipruritic application of ovocystatin in atopic dermatitis in dogs - preliminary study Cover

Antipruritic application of ovocystatin in atopic dermatitis in dogs - preliminary study

Open Access
|Dec 2014

References

  1. 1. Anastasi A., Brown M.A., Kembhavi A.A., Nicklin M.J., Sayers C.A., Sunter D.C., Barrett A.J.: Cystatin, a protein inhibitor of cystein proteinase. Improved purification from egg white, characterization and detection in chicken serum. Biochem J 1983, 211, 129-138.10.1042/bj2110129
  2. 2. Barrett A.J.: Cystatin, the egg white inhibitor of cysteine proteinase. Meth Enzymol 1981, 80, 771-778.10.1016/S0076-6879(81)80059-6
  3. 3. Bensignor E., Olivry T.: Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. Vet Dermatol 2005, 16, 52-60.10.1111/j.1365-3164.2005.00419.x
  4. 4. DeBoer D.J., Hiller A.: The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Vet Immunol Immunopathol 2001, 81, 271-276.10.1016/S0165-2427(01)00312-9
  5. 5. DeRie M.A., Mainardi M.H.M., Dos J.: Lack of efficacy of topical cyclosporine A in atopic and allergic contact dermatitis. Acta Dermatol 1991, 71, 452-454.
  6. 6. Favrot C., Steffan J., Seewald W.: A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010, 21, 23-30.10.1111/j.1365-3164.2009.00758.x
  7. 7. Gołąb K., Warwas M.: Chicken egg proteins- biochemical properties and applications. Adv Clin Exp Med 2005, 14, 1001-1010.
  8. 8. Gołąb K., Gburek J., Juszczyńska K., Trziszka T., Polanowski A.: Stabilization of monomeric hen’s egg white cyststin. Chem Industry 2012, 91, 741-744.
  9. 9. Gross T.L., Walder E.J., Ihrke P.J.: Subepidermal bullous dermatosis due to topical corticosteroid therapy in dogs. Vet Dermatol 1997, 8, 127-131.10.1046/j.1365-3164.1997.d01-3.x
  10. 10. Hill P.B., Lau P., Rybnicek J.: Development of an owner-assessed scale to measure the severity of pruritus in dogs. Vet Dermatol 2007, 18, 301-308.10.1111/j.1365-3164.2007.00616.x
  11. 11. Hill. P., Rybnicek J., Lau-Gillard P.: Correlation between pruritus score and grossly visible erythema in dogs. Vet Dermatol 2010, 21, 450-455.10.1111/j.1365-3164.2010.00881.x
  12. 12. Ikoma A., Steinhoff M., Stander S., Yosipovitch G., Schmelz M.: The neurobiology of itch. Nature Rev Neurosci 2006, 7, 534-547.10.1038/nrn1950
  13. 13. Machleidt W., Nagler D.K., Machleidt I.A., Stubbs M.T., Fritz H., Auerswald E.A.: Temporary inhibition of papain by hairpin loop mutants of Chicken Cystatin. Distorted binding of the loops results in cleavage of the Gly-Ala bond. FEBS Lett 1995, 361, 185-190.10.1016/0014-5793(95)00174-8
  14. 14. Marsella R., Nicklin C.F., Sagilo S.: Investigation on the clnical efficacy and safety of 0.1% tacrolimus ointment (protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo- controlled, cross-over study. Vet Dermatol 2004, 15, 294-303.10.1111/j.1365-3164.2004.00397.x
  15. 15. Migozuchi M., Kawaguchi K., Ohsauga Y., Ikary Y., Yanagawa A., Mizushima Y.: Cyclosporine ointment for psoriasis and atopic dermatitis. Lancet 1992, 339, 1120.10.1016/0140-6736(92)90719-J
  16. 16. Nutall T., Mueller R., Bensignor E.: Efficacy of a 0.0584% hydrocortisone aceponante spray in management of canine atopic dermatitis: a randomised, double blind, placebo controlled trials. Vet Dermatol 2009, 20, 191-198.
  17. 17. Olivry T. Marsella R., Iwasaki T., Mueller R.: Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 2007, 18, 78-86.10.1111/j.1365-3164.2007.00569.x17355421
  18. 18. Olivry T., Mueller R., Nuttall T., Favrot C., Prelaud P.: Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis. Vet Dermatol 2008, 19, 115-119.10.1111/j.1365-3164.2008.00668.x18477326
  19. 19. Olivry T.: New diagnostic criteria for canine atopic dermatitis (Letter to the Editor). Vet Dermatol 2010, 21, 124-12710.1111/j.1365-3164.2009.00776.x20187919
  20. 20. Olivry T., DeBoer D.J., Favrot C., Jackson H.A., Mueller R.S., Nuttall T., Prelaud P.: Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol 2010, 21, 233-248.10.1111/j.1365-3164.2010.00889.x20456716
  21. 21. Rybnicek J., Lau-Gillard P.J., Harvey R., Hill P.B.: Further validation of a pruritus severity scale for use in dogs. Vet Dermatol 2009, 20, 115-122.10.1111/j.1365-3164.2008.00728.x19171021
  22. 22. Saevik B.K., Bergvall K., Holm B.R., Saijonmaa- Koulumiess L.E., Hedhammar A., Larsen S., Kristensen F.: A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acids supplementation in treatment of canine atopic dermatitis. Vet Dermatol 2004, 15, 137-145.10.1111/j.1365-3164.2004.00378.x15214949
  23. 23. Trziszka T., Polanowski A., Saleh Y., Kopeć W.: Egg white isolation and its medical application. 2006, http://www.animalscience.com/uploads/additionalfiles/wpsaverona.htmL.
  24. 24. Umemoto T., Naito Y., Li M., Sazuki I., Namikawa I.: Growth inhibition of a human oral bacterium Porphyromonas gingivialis by rat cysteine proteinase inhibitor Cystatin S. Lett Appl Microbiol 1996, 23, 151-153.10.1111/j.1472-765X.1996.tb00052.x8862019
  25. 25. Zerownik E., Cimerman N., Kos J., Turk V., Lohner K.: Thermal denaturatiom of human cystatin C and two of its variants.
  26. Comparsion to chicken cystatin. Biol Chem 1997, 378, 1199-1203.
Language: English
Page range: 639 - 643
Submitted on: Jun 19, 2014
Accepted on: Oct 10, 2014
Published on: Dec 20, 2014
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Jarosław Popiel, Agnieszka Cekiera, Agnieszka Kurosad, Urszula Pasławska, Agnieszka Noszczyk-Nowak, Józef Nicpo, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.